Side-by-side financials for BVS and MDLN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BVS | MDLN |
|---|---|---|
| Market cap | - | $49.12 B |
| US-listed rank | - | #329 |
| Revenue (latest FY) | $568.09M | $28.43B |
| Net income (latest FY) | $22.73M | $1.16T |
| Net margin | 4.0% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 445 | 103 |
In their latest fiscal years, Bioventus Inc. reported $568.09M in revenue while Medline Inc. reported $28.43B.
Full pages: Bioventus Inc. and Medline Inc., or browse the full rankings.